These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24130751)

  • 1. GCN2 in the brain programs PPARγ2 and triglyceride storage in the liver during perinatal development in response to maternal dietary fat.
    Xu X; Hu J; McGrath BC; Cavener DR
    PLoS One; 2013; 8(10):e75917. PubMed ID: 24130751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCN2 Deficiency Enhances Protective Effects of Exercise on Hepatic Steatosis.
    Luo X; Shi X; Sun Z; Xiao J; Song H; Lu G; Xu X
    Biomed Res Int; 2020; 2020():1454396. PubMed ID: 33299856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GCN2 is required to increase fibroblast growth factor 21 and maintain hepatic triglyceride homeostasis during asparaginase treatment.
    Wilson GJ; Lennox BA; She P; Mirek ET; Al Baghdadi RJ; Fusakio ME; Dixon JL; Henderson GC; Wek RC; Anthony TG
    Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E283-93. PubMed ID: 25491724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary β-conglycinin prevents fatty liver induced by a high-fat diet by a decrease in peroxisome proliferator-activated receptor γ2 protein.
    Yamazaki T; Kishimoto K; Miura S; Ezaki O
    J Nutr Biochem; 2012 Feb; 23(2):123-32. PubMed ID: 21447441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
    Kim JH; Jung DY; Nagappan A; Jung MH
    Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aronia melanocarpa Extract Ameliorates Hepatic Lipid Metabolism through PPARγ2 Downregulation.
    Park CH; Kim JH; Lee EB; Hur W; Kwon OJ; Park HJ; Yoon SK
    PLoS One; 2017; 12(1):e0169685. PubMed ID: 28081181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
    Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
    J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid.
    Guo F; Cavener DR
    Cell Metab; 2007 Feb; 5(2):103-14. PubMed ID: 17276353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of mitogen-activated protein kinase phosphatase-1 protects from hepatic steatosis by repression of cell death-inducing DNA fragmentation factor A (DFFA)-like effector C (CIDEC)/fat-specific protein 27.
    Flach RJ; Qin H; Zhang L; Bennett AM
    J Biol Chem; 2011 Jun; 286(25):22195-202. PubMed ID: 21521693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
    Park S; Yoo S; Kim J; An HT; Kang M; Ko J
    Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt2 is required for hepatic lipid accumulation in models of insulin resistance.
    Leavens KF; Easton RM; Shulman GI; Previs SF; Birnbaum MJ
    Cell Metab; 2009 Nov; 10(5):405-18. PubMed ID: 19883618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver GCN2 controls hepatic FGF21 secretion and modulates whole body postprandial oxidation profile under a low-protein diet.
    Chalvon-Demersay T; Moro J; Even PC; Chaumontet C; Tomé D; Averous J; Piedcoq J; Gaudichon C; Maurin AC; Fafournoux P; Azzout-Marniche D
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1015-E1021. PubMed ID: 31573843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Per-Arnt-Sim Kinase (PASK) Deficiency Increases Cellular Respiration on a Standard Diet and Decreases Liver Triglyceride Accumulation on a Western High-Fat High-Sugar Diet.
    Pape JA; Newey CR; Burrell HR; Workman A; Perry K; Bikman BT; Bridgewater LC; Grose JH
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30558306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GCN2 inhibitor IMPACT contributes to diet-induced obesity and body temperature control.
    Pereira CM; Filev R; Dubiela FP; Brandão BB; Queiroz CM; Ludwig RG; Hipolide D; Longo BM; Mello LE; Mori MA; Castilho BA
    PLoS One; 2019; 14(6):e0217287. PubMed ID: 31166980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models.
    Newberry EP; Kennedy SM; Xie Y; Luo J; Stanley SE; Semenkovich CF; Crooke RM; Graham MJ; Davidson NO
    Hepatology; 2008 Oct; 48(4):1097-105. PubMed ID: 18697204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of Fsp27 by the liver-enriched transcription factor CREBH promotes lipid droplet growth and hepatic steatosis.
    Xu X; Park JG; So JS; Lee AH
    Hepatology; 2015 Mar; 61(3):857-69. PubMed ID: 25125366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.
    Gavrilova O; Haluzik M; Matsusue K; Cutson JJ; Johnson L; Dietz KR; Nicol CJ; Vinson C; Gonzalez FJ; Reitman ML
    J Biol Chem; 2003 Sep; 278(36):34268-76. PubMed ID: 12805374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor.
    Lin HY; Yu IC; Wang RS; Chen YT; Liu NC; Altuwaijri S; Hsu CL; Ma WL; Jokinen J; Sparks JD; Yeh S; Chang C
    Hepatology; 2008 Jun; 47(6):1924-35. PubMed ID: 18449947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.